Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo.

Frommhold D, Mannigel I, Schymeinsky J, Mocsai A, Poeschl J, Walzog B, Sperandio M.

BMC Immunol. 2007 Nov 28;8:31.

2.

The Vav binding site of the non-receptor tyrosine kinase Syk at Tyr 348 is critical for beta2 integrin (CD11/CD18)-mediated neutrophil migration.

Schymeinsky J, Sindrilaru A, Frommhold D, Sperandio M, Gerstl R, Then C, Mócsai A, Scharffetter-Kochanek K, Walzog B.

Blood. 2006 Dec 1;108(12):3919-27. Epub 2006 Aug 1.

3.

Pyk2 and Syk participate in functional activation of granulocytic HL-60 cells in a different manner.

Miura Y, Tohyama Y, Hishita T, Lala A, De Nardin E, Yoshida Y, Yamamura H, Uchiyama T, Tohyama K.

Blood. 2000 Sep 1;96(5):1733-9.

4.

Lipid Raft is required for PSGL-1 ligation induced HL-60 cell adhesion on ICAM-1.

Xu T, Liu W, Luo J, Li C, Ba X, Ampah KK, Wang X, Jiang Y, Zeng X.

PLoS One. 2013 Dec 3;8(12):e81807. doi: 10.1371/journal.pone.0081807. eCollection 2013.

6.

Ezrin-radixin-moesin-binding sequence of PSGL-1 glycoprotein regulates leukocyte rolling on selectins and activation of extracellular signal-regulated kinases.

Spertini C, Baïsse B, Spertini O.

J Biol Chem. 2012 Mar 23;287(13):10693-702. doi: 10.1074/jbc.M111.318022. Epub 2012 Feb 6.

7.

Separable requirements for cytoplasmic domain of PSGL-1 in leukocyte rolling and signaling under flow.

Miner JJ, Xia L, Yago T, Kappelmayer J, Liu Z, Klopocki AG, Shao B, McDaniel JM, Setiadi H, Schmidtke DW, McEver RP.

Blood. 2008 Sep 1;112(5):2035-45. doi: 10.1182/blood-2008-04-149468. Epub 2008 Jun 11.

8.

A role for Syk-kinase in the control of the binding cycle of the beta2 integrins (CD11/CD18) in human polymorphonuclear neutrophils.

Willeke T, Schymeinsky J, Prange P, Zahler S, Walzog B.

J Leukoc Biol. 2003 Aug;74(2):260-9.

PMID:
12885943
9.

Syk activation is required for spreading and H2O2 release in adherent human neutrophils.

Fernandez R, Suchard SJ.

J Immunol. 1998 May 15;160(10):5154-62.

10.

Leukocyte arrest during cytokine-dependent inflammation in vivo.

Kunkel EJ, Dunne JL, Ley K.

J Immunol. 2000 Mar 15;164(6):3301-8.

11.

Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis.

Jakus Z, Simon E, Frommhold D, Sperandio M, Mócsai A.

J Exp Med. 2009 Mar 16;206(3):577-93. doi: 10.1084/jem.20081859. Epub 2009 Mar 9.

12.

RAGE and ICAM-1 differentially control leukocyte recruitment during acute inflammation in a stimulus-dependent manner.

Frommhold D, Kamphues A, Dannenberg S, Buschmann K, Zablotskaya V, Tschada R, Lange-Sperandio B, Nawroth PP, Poeschl J, Bierhaus A, Sperandio M.

BMC Immunol. 2011 Oct 4;12:56. doi: 10.1186/1471-2172-12-56.

13.

Leukocyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo.

Smith DF, Deem TL, Bruce AC, Reutershan J, Wu D, Ley K.

J Leukoc Biol. 2006 Dec;80(6):1491-9. Epub 2006 Sep 22.

PMID:
16997858
15.

Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways.

Mueller H, Stadtmann A, Van Aken H, Hirsch E, Wang D, Ley K, Zarbock A.

Blood. 2010 Apr 15;115(15):3118-27. doi: 10.1182/blood-2009-11-254185. Epub 2010 Feb 18.

17.

Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection.

Van Ziffle JA, Lowell CA.

Blood. 2009 Nov 26;114(23):4871-82. doi: 10.1182/blood-2009-05-220806. Epub 2009 Oct 1.

18.

Transit time of leukocytes rolling through venules controls cytokine-induced inflammatory cell recruitment in vivo.

Jung U, Norman KE, Scharffetter-Kochanek K, Beaudet AL, Ley K.

J Clin Invest. 1998 Oct 15;102(8):1526-33.

19.
20.

Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation.

Dunne JL, Collins RG, Beaudet AL, Ballantyne CM, Ley K.

J Immunol. 2003 Dec 1;171(11):6105-11.

Supplemental Content

Support Center